We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

THAR Tharimmune Inc

-0.0211 (-2.89%)
Dec 05 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 4,028,640
Bid Price 0.70
Ask Price 0.71
News -
Day High 0.765


52 Week Range


Day Low 0.6873
Company Name Stock Ticker Symbol Market Type
Tharimmune Inc THAR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0211 -2.89% 0.71 19:59:34
Open Price Low Price High Price Close Price Prev Close
0.765 0.6873 0.765 0.7002 0.7311
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
27,151 4,028,640 $ 0.7112513 $ 2,865,375 - 0.6873 - 9.50
Last Trade Time Type Quantity Stock Price Currency
19:59:36 10 $ 0.70 USD

Tharimmune Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.99M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Tharimmune News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No THAR Message Board. Create One! See More Posts on THAR Message Board See More Message Board Posts

Historical THAR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.061.080.68730.90616833,409,357-0.35-33.02%
1 Month6.52256.750.68734.664,825,573-5.81-89.11%
3 Months5.509.500.68735.333,053,344-4.79-87.09%
6 Months5.509.500.68735.333,053,344-4.79-87.09%
1 Year5.509.500.68735.333,053,344-4.79-87.09%
3 Years5.509.500.68735.333,053,344-4.79-87.09%
5 Years5.509.500.68735.333,053,344-4.79-87.09%

Tharimmune Description

Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron-mediated cell death for drug-resistant and devastating cancers.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |